Marker Therapeutics Inc MRKR:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 4:00 PM EDT
4.21quote price arrow up+0.19 (+4.73%)
Volume
10,099
52 week range
1.16 - 9.68
Loading...
  • Open4.00
  • Day High4.35
  • Day Low4.00
  • Prev Close4.02
  • 52 Week High9.68
  • 52 Week High Date07/26/23
  • 52 Week Low1.16
  • 52 Week Low Date05/26/23

Key Stats

  • Market Cap37.526M
  • Shares Out8.91M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta1.62
  • YTD % Change-22.36

KEY STATS

  • Open4.00
  • Day High4.35
  • Day Low4.00
  • Prev Close4.02
  • 52 Week High9.68
  • 52 Week High Date07/26/23
  • 52 Week Low1.16
  • 52 Week Low Date05/26/23
  • Market Cap37.526M
  • Shares Out8.91M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta1.62
  • YTD % Change-22.36

RATIOS/PROFITABILITY

  • EPS (TTM)-1.59
  • P/E (TTM)-2.64
  • Fwd P/E (NTM)-1.24
  • EBITDA (TTM)-13.763M
  • ROE (TTM)-83.47%
  • Revenue (TTM)3.311M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-424.20%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Marker Therapeutics Inc

 

Profile

MORE
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company. The Company specializes in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. It has developed its lead product candidates from its multiTAA-specific T cell technology, which is based on the manufacture of non-engineered, tumor-specific T cells that recognize multiple tumors associated antigens (TAAs)...
N. David Eansor
Independent Chairman of the Board
Juan Vera M.D.
President, Chief Executive Officer, Principal Financial and Accounting Officer, Director
Anna Szymanska
Vice President - Quality
Nadia Agopyan Ph.D.
Vice President - Regulatory Affairs
Address
4551 KENNEDY COMMERCE DR.
Houston, TX
77032
United States

Top Peers

SYMBOLLASTCHG%CHG
BOLT
Bolt Biotherapeutics Inc
1.11+0.03+2.78%
SPRB
Spruce Biosciences Inc
0.8455+0.046+5.7536%
PTN
Palatin Technologies Inc
2.05-0.03-1.44%
IKNA
Ikena Oncology Inc
1.37-0.04-2.84%
TCON
TRACON Pharmaceuticals Inc
1.76-0.06-3.30%